(MedPage Today) — The FDA is investigating the deaths of two boys with Duchenne muscular dystrophy who died soon after being treated with delandistrogene moxeparvovec (Elevidys) gene therapy, the agency said.
The investigation will focus on the…
Source link : https://www.medpagetoday.com/neurology/generalneurology/116234
Author :
Publish date : 2025-06-25 13:26:00
Copyright for syndicated content belongs to the linked Source.
